NEW MILTON, U.K. and BOSTON--(BUSINESS WIRE)--Genetix Group plc (AIM:GTX), the cancer diagnostic and biopharmaceutical technologies group (www.genetix.com), has been granted US Patent No. 7,310,147. The patent covers a number of important features that include the integration of imaging capabilities into Genetix robotic platforms, most notably the ClonePix FL. It also provides Genetix with intellectual property rights in the US market for robots with integrated optics for single and multi-wavelength excitation and spectroscopic analysis of cells and cell colonies.
